Cargando…
Bisphosphonate and risk of cancer recurrence: protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials
INTRODUCTION: No consensus exists on the associations between adjuvant treatment with bisphosphonates and cancer recurrence risk among patients with primary early-stage cancers. We plan to perform a comprehensive systematic review, study-level meta-analysis and trial sequential analysis of randomise...
Autores principales: | Liu, Yupeng, Du, Chen, Zhang, Yuxue, Zhao, Shu, Zhao, Lina, Li, Pengfei, Hu, Fulan, Zhu, Lin, Liu, Yanlong, Pang, Da, Zhao, Yashuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410126/ https://www.ncbi.nlm.nih.gov/pubmed/25900461 http://dx.doi.org/10.1136/bmjopen-2014-007215 |
Ejemplares similares
-
Bisphosphonates and breast cancer survival: a meta-analysis and trial sequential analysis of 81508 participants from 23 prospective epidemiological studies
por: Liu, YuPeng, et al.
Publicado: (2021) -
Insulin-like growth factor 2 hypermethylation in peripheral blood leukocytes and colorectal cancer risk and prognosis: a propensity score analysis
por: Sun, HongRu, et al.
Publicado: (2023) -
Bisphosphonates and primary breast cancer risk: an updated systematic review and meta-analysis involving 963,995 women
por: Liu, Yupeng, et al.
Publicado: (2019) -
Long Noncoding RNA MALAT1 and Colorectal Cancer: A Propensity Score Analysis of Two Prospective Cohorts
por: Li, Heng, et al.
Publicado: (2022) -
A Propensity Score-adjusted Analysis of the Effects of Ubiquitin E3 Ligase Copy Number Variation in Peripheral Blood Leukocytes on Colorectal Cancer Risk
por: Bi, Haoran, et al.
Publicado: (2019)